[1]
Wang CS, Greenbaum LA. Nephrotic Syndrome. Pediatric clinics of North America. 2019 Feb:66(1):73-85. doi: 10.1016/j.pcl.2018.08.006. Epub
[PubMed PMID: 30454752]
[2]
Bonney KM, Luthringer DJ, Kim SA, Garg NJ, Engman DM. Pathology and Pathogenesis of Chagas Heart Disease. Annual review of pathology. 2019 Jan 24:14():421-447. doi: 10.1146/annurev-pathol-020117-043711. Epub 2018 Oct 24
[PubMed PMID: 30355152]
[3]
Wang G, Cao WG, Zhao TL. Fluid management in extensive liposuction: A retrospective review of 83 consecutive patients. Medicine. 2018 Oct:97(41):e12655. doi: 10.1097/MD.0000000000012655. Epub
[PubMed PMID: 30313055]
Level 2 (mid-level) evidence
[4]
Patel H, Skok C, DeMarco A. Peripheral Edema: Evaluation and Management in Primary Care. American family physician. 2022 Nov:106(5):557-564
[PubMed PMID: 36379502]
[5]
Abassi Z, Khoury EE, Karram T, Aronson D. Edema formation in congestive heart failure and the underlying mechanisms. Frontiers in cardiovascular medicine. 2022:9():933215. doi: 10.3389/fcvm.2022.933215. Epub 2022 Sep 27
[PubMed PMID: 36237903]
[6]
Kallash M, Mahan JD. Mechanisms and management of edema in pediatric nephrotic syndrome. Pediatric nephrology (Berlin, Germany). 2021 Jul:36(7):1719-1730. doi: 10.1007/s00467-020-04779-x. Epub 2020 Nov 20
[PubMed PMID: 33216218]
[7]
Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. Journal of veterinary internal medicine. 2019 Mar:33(2):383-402. doi: 10.1111/jvim.15406. Epub 2019 Feb 14
[PubMed PMID: 30762910]
Level 2 (mid-level) evidence
[8]
Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. American family physician. 2013 Jul 15:88(2):102-10
[PubMed PMID: 23939641]
[9]
Schildt EE, De Ranieri D. Anasarca as the presenting symptom of juvenile dermatomyositis: a case series. Pediatric rheumatology online journal. 2021 Aug 13:19(1):120. doi: 10.1186/s12969-021-00604-3. Epub 2021 Aug 13
[PubMed PMID: 34389019]
Level 2 (mid-level) evidence
[10]
Meena SP, Sairam MV, Puranik AK, Badkur M, Sharma N, Lodha M, Rohda MS, Kothari N. Risk Factors and Patient Outcomes Associated With Immediate Post-operative Anasarca Following Major Abdominal Surgeries: A Prospective Observational Study From 2019 to 2021. Cureus. 2021 Dec:13(12):e20631. doi: 10.7759/cureus.20631. Epub 2021 Dec 23
[PubMed PMID: 34963874]
Level 2 (mid-level) evidence
[11]
Klanderman RB, Bosboom JJ, Migdady Y, Veelo DP, Geerts BF, Murphy MF, Vlaar APJ. Transfusion-associated circulatory overload-a systematic review of diagnostic biomarkers. Transfusion. 2019 Feb:59(2):795-805. doi: 10.1111/trf.15068. Epub 2018 Nov 29
[PubMed PMID: 30488959]
Level 1 (high-level) evidence
[12]
Gradalski T. Edema of Advanced Cancer: Prevalence, Etiology, and Conservative Management-A Single Hospice Cross-Sectional Study. Journal of pain and symptom management. 2019 Feb:57(2):311-318. doi: 10.1016/j.jpainsymman.2018.11.005. Epub 2018 Nov 17
[PubMed PMID: 30453053]
[13]
Krogh A, Landis EM, Turner AH. THE MOVEMENT OF FLUID THROUGH THE HUMAN CAPILLARY WALL IN RELATION TO VENOUS PRESSURE AND TO THE COLLOID OSMOTIC PRESSURE OF THE BLOOD. The Journal of clinical investigation. 1932 Jan:11(1):63-95
[PubMed PMID: 16694035]
[14]
Ellis D. Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome. Frontiers in pediatrics. 2015:3():111. doi: 10.3389/fped.2015.00111. Epub 2016 Jan 11
[PubMed PMID: 26793696]
[15]
Sabar R, Safadi W. Relieving the burden: palliative centesis of an oedematous scrotal wall due to anasarca in end-stage heart failure. BMJ case reports. 2013 Sep 6:2013():. doi: 10.1136/bcr-2013-009388. Epub 2013 Sep 6
[PubMed PMID: 24014556]
Level 3 (low-level) evidence
[16]
Nobbe AM, McCurdy HM. Management of the Adult Patient with Cirrhosis Complicated by Ascites. Critical care nursing clinics of North America. 2022 Sep:34(3):311-320. doi: 10.1016/j.cnc.2022.04.005. Epub 2022 Jul 20
[PubMed PMID: 36049850]
[17]
Thakrar DB, Sultan MJ. Cellulitis: diagnosis and differentiation. Journal of wound care. 2021 Dec 2:30(12):958-965. doi: 10.12968/jowc.2021.30.12.958. Epub
[PubMed PMID: 34881996]
[18]
Sabanova EA, Fadeyev VV, Potekaev NN, Lvov AN. [Pretibial myxedema: pathogenetic features and clinical aspects]. Problemy endokrinologii. 2019 Jun 30:65(2):134-138. doi: 10.14341/probl9848. Epub 2019 Jun 30
[PubMed PMID: 31271716]
[19]
Sener D, Halil M, Yavuz BB, Cankurtaran M, Arioğul S. Anasarca edema with amlodipine treatment. The Annals of pharmacotherapy. 2005 Apr:39(4):761-3
[PubMed PMID: 15728328]
[20]
Montazeripouragha A, Campbell CM, Russell J, Medvedev N, Owen DR, Harris A, Donnellan F, McCormick I, Fajgenbaum DC, Chen LYC. Thrombocytopenia, anasarca, and severe inflammation. American journal of hematology. 2022 Oct:97(10):1374-1380. doi: 10.1002/ajh.26651. Epub 2022 Jul 19
[PubMed PMID: 35794839]
[21]
Nakaya H, Okamoto R, Nagashima K, Sugino Y, Ogihara Y, Sakuma H, Dohi K. Elderly Man With "Overalls" Edema. Circulation journal : official journal of the Japanese Circulation Society. 2022 Jan 25:86(2):333. doi: 10.1253/circj.CJ-21-0700. Epub 2021 Sep 15
[PubMed PMID: 34526441]
[22]
Gbadamosi WA, Melvin J, Lopez M. Atypical Case of Minoxidil-Induced Generalized Anasarca and Pleuropericardial Effusion. Cureus. 2021 Jun:13(6):e15424. doi: 10.7759/cureus.15424. Epub 2021 Jun 3
[PubMed PMID: 34249570]
Level 3 (low-level) evidence
[23]
Jinadasa AGRG, Srimantha LASM, Siriwardhana ID, Gunawardana KB, Attanayake AP. Optimization of 25% Sulfosalicylic Acid Protein-to-Creatinine Ratio for Screening of Low-Grade Proteinuria. International journal of analytical chemistry. 2021:2021():6688941. doi: 10.1155/2021/6688941. Epub 2021 Jan 28
[PubMed PMID: 33574847]
[24]
Kuwahara K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacology & therapeutics. 2021 Nov:227():107863. doi: 10.1016/j.pharmthera.2021.107863. Epub 2021 Apr 21
[PubMed PMID: 33894277]
[25]
Zhou L, Yin X, Zhang T, Feng Y, Zhao Y, Jin M, Peng M, Xing C, Li F, Wang Z, Wei G, Jia X, Liu Y, Wu X, Lu L. Detection and Semiquantitative Analysis of Cardiomegaly, Pneumothorax, and Pleural Effusion on Chest Radiographs. Radiology. Artificial intelligence. 2021 Jul:3(4):e200172. doi: 10.1148/ryai.2021200172. Epub 2021 May 19
[PubMed PMID: 34350406]
[26]
Dopp H, Maagh P, Meissner A. [Heart Failure Despite Low BNP-Level: Paradoxon or Pathfinder? - - A Case of Pericarditis constrictiva]. Deutsche medizinische Wochenschrift (1946). 2018 May:143(10):731-734. doi: 10.1055/a-0600-1645. Epub 2018 May 4
[PubMed PMID: 29727888]
Level 3 (low-level) evidence
[27]
Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC nephrology. 2016 Aug 2:17(1):109. doi: 10.1186/s12882-016-0323-6. Epub 2016 Aug 2
[PubMed PMID: 27484681]
[28]
WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15:128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5
[PubMed PMID: 23741058]
Level 1 (high-level) evidence
[29]
Bellomo R, Prowle JR, Echeverri JE. Diuretic therapy in fluid-overloaded and heart failure patients. Contributions to nephrology. 2010:164():153-163. doi: 10.1159/000313728. Epub 2010 Apr 20
[PubMed PMID: 20428001]
[30]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of hepatology. 2018 Aug:69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10
[PubMed PMID: 29653741]
Level 1 (high-level) evidence
[31]
Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E, Galioto A, Salinas F, D'Aquino M, Sticca A, Gatta A. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut. 2010 Jan:59(1):98-104. doi: 10.1136/gut.2008.176495. Epub
[PubMed PMID: 19570764]
Level 1 (high-level) evidence
[32]
Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology (Baltimore, Md.). 2003 Jul:38(1):258-66
[PubMed PMID: 12830009]
Level 3 (low-level) evidence
[33]
Perri GA. Ascites in patients with cirrhosis. Canadian family physician Medecin de famille canadien. 2013 Dec:59(12):1297-9; e538-40
[PubMed PMID: 24336542]
[34]
Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology (Baltimore, Md.). 2013 Apr:57(4):1651-3. doi: 10.1002/hep.26359. Epub
[PubMed PMID: 23463403]
Level 1 (high-level) evidence
[36]
Kodner C. Diagnosis and Management of Nephrotic Syndrome in Adults. American family physician. 2016 Mar 15:93(6):479-85
[PubMed PMID: 26977832]
[37]
Pereira de Godoy JM, Pereira de Godoy HJ, Lopes Pinto R, Facio FN Jr, Guerreiro Godoy MF. Maintenance of the Results of Stage II Lower Limb Lymphedema Treatment after Normalization of Leg Size. International journal of vascular medicine. 2017:2017():8515767. doi: 10.1155/2017/8515767. Epub 2017 Aug 1
[PubMed PMID: 28835857]
[38]
Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A. Anasarca: not a nephrotic syndrome but dermatomyositis. European journal of pediatrics. 2008 Jul:167(7):831-4. doi: 10.1007/s00431-008-0716-z. Epub 2008 Apr 15
[PubMed PMID: 18414893]
[39]
Nara M, Komatsuda A, Itoh F, Kaga H, Saitoh M, Togashi M, Kameoka Y, Wakui H, Takahashi N. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging. Internal medicine (Tokyo, Japan). 2017:56(10):1247-1252. doi: 10.2169/internalmedicine.56.7991. Epub 2017 May 15
[PubMed PMID: 28502946]
Level 3 (low-level) evidence
[40]
Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. American journal of hematology. 2021 Oct 1:96(10):1241-1252. doi: 10.1002/ajh.26292. Epub 2021 Jul 28
[PubMed PMID: 34265103]
[41]
Oka S, Ono K. Successful treatment of systemic AL amyloidosis with autologous hematopoietic stem cell transplantation combined with cell-free and concentrated ascites reinfusion therapy. Clinical case reports. 2023 May:11(5):e7233. doi: 10.1002/ccr3.7233. Epub 2023 May 9
[PubMed PMID: 37180320]
Level 3 (low-level) evidence
[42]
Peng Y, Qi X, Guo X. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine. 2016 Feb:95(8):e2877. doi: 10.1097/MD.0000000000002877. Epub
[PubMed PMID: 26937922]
Level 1 (high-level) evidence
[43]
Kumar P, Khan IA, Das A, Shah H. Chronic venous disease. Part 1: pathophysiology and clinical features. Clinical and experimental dermatology. 2022 Jul:47(7):1228-1239. doi: 10.1111/ced.15143. Epub 2022 Apr 5
[PubMed PMID: 35167156]